Immunotherapy drug for treating HPV+ head and neck cancers hailed as "game-changer"
A new generation of “game-changing” drugs that harness the body’s immune system have been found to extend the lives of head and neck cancer sufferers. The drug, Nivolumab, resulted in the doubling of one-year survival rates in clinical trials on HPV+ head and neck cancer patients. Findings will be presented to the European Society for Medical Oncology Conference taking place in Copenhagen this week. Nivolumab works by removing the switch so that immune cells can spot cancer cells and clear them out of the body. Oracle’s Honorary Trustee, Professor Kevin Harrington, led this exciting trial.
Read the full article here https://www.bbc.co.uk/news/health-37588541
Charity Administrator Job – We’re recruiting
We are looking for a dedicated Administrator to join our team.
Oracle´s Golf Day 2025 – Sonning GC, Reading
Oracle´s annual golf day is on 13th June 2025 at Sonning Golf Club, Reading.
Oracle´s annual Oncology meeting
meeting to discuss cutting edge advancements in the treatment of head and neck cancer
Cancer Treatment Wait Times risking lives
Patients face long delays, only 50% seen within the NHS target of 62 days.
Jamie Theakston announces Laryngeal cancer diagnosis
Jamie has had a lesion removed from his vocal chords (Larynx)
Make Sense Campaign 2024
Oracle Head & Neck Cancer UK Supports Make Sense Campaign 2024 Raising Awareness for Head and Neck Cancer We are proud to support the Make Sense Campaign (16th – 21st…
News coverage heralds the start of annual HPV vaccinations
Another busy week for Oracle HNCUK promoting the start of the annual autumn HPV vaccination programme for year 8 children in UK high schools.
Cancer Support Group 6 Year Anniversary
“We could never have imagined just how amazing it would be and just how supportive you would all be to each other”
Respiratory-Swallow Training in Head and Neck Cancer
New training, which aims to change the breathing-swallowing pattern of patients with swallowing difficulties, has been developed in America.
EasyJet Boarding Pass – Check in and check out information on head & neck cancers.
An estimated 40,000 passengers are being told to ‘Silence the threat. Give it the check’ in the our latest campaign.